Showing results (1041-1050 of 1,137) with videos related to
Sort By:
Pageof 114
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2019
High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T CellsCarla Costa-Nunes, Amélie Cachot, Sara Bobisse, et al.Cancer Immunity|June 28, 2008
Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancerPedro M S Alves, Nicole Lévy, Brian J Stevenson, et al.Radiation Oncology (London, England)|May 10, 2012
An athymic rat model of cutaneous radiation injury designed to study human tissue-based wound therapyLucas H Rifkin, Strahinja Stojadinovic, Collin H Stewart, et al.Cell Reports Methods|May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.Circulation|August 28, 2002
Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosisJeffrey J Popma, Mohan Suntharalingam, Alexandra J Lansky, et al.European Journal of Cancer (Oxford, England : 1990)|November 2, 2013
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortiumDietmar Pils, Anna Bachmayr-Heyda, Katharina Auer, et al.Science Translational Medicine|September 15, 2017
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanomaManuel Fankhauser, Maria A S Broggi, Lambert Potin, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2013
[6,6]-Open and [6,6]-closed isomers of C70(CF2): synthesis, electrochemical and quantum chemical investigationNataliya A Samoylova, Nikita M Belov, Victor A Brotsman, et al.European Urology|March 10, 2017
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial CancerMathieu F Chevalier, Perrine Bohner, Claire Pieraerts, et al.Science Translational Medicine|September 19, 2014
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell responsePia Kvistborg, Daisy Philips, Sander Kelderman, et al.Pageof 114